SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-18-003977
Filing Date
2018-04-03
Accepted
2018-04-03 16:01:14
Documents
1
Period of Report
2018-03-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4033018bacha_delmar.html 4  
1 OWNERSHIP DOCUMENT f4033018bacha_delmar.xml 4 3268
  Complete submission text file 0001213900-18-003977.txt   4717
Mailing Address SUITE 3 1545 WEST 14TH AVENUE VANCOUVER A1 V6J 2J1
Business Address
BACHA JEFFREY (Reporting) CIK: 0001432149 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37823 | Film No.: 18733253

Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Issuer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations